Canagliflozin: all 123 studies that test it
Page 2 of 2. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of an Oral Contraceptive in Healthy VolunteersCompletedNCT01714193Phase 1
- A Study to Assess the Pharmacokinetics and Pharmacodynamics of Canagliflozin in Healthy Chinese VolunteersCompletedNCT01707316Phase 1
- Effects of Canagliflozin on C-peptide Clearance in Healthy VolunteersCompletedNCT01665638Phase 1
- A Study of Canagliflozin and Metformin Immediate Release (50 mg/500 mg) FDC Tablets in Healthy VolunteersCompletedNCT01508195Phase 1
- A Study of Canagliflozin and Metformin Immediate Release (150 mg/500 mg) FDC Tablets in Healthy VolunteersCompletedNCT01508182Phase 1
- A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes MellitusCompletedNCT01483781Phase 1
- A Study to Assess the Bioequivalence of 2 Fixed Dose Combination Tablets of Canagliflozin and Metformin Immediate Release (IR) With Respect to the Individual Components of Canagliflozin and Metformin IR Tablets in Healthy VolunteersCompletedNCT01463774Phase 1
- A Study to Assess the Effects of Multiple-Dose Probenecid on the Multiple-Dose Pharmacokinetics of Canagliflozin in Healthy VolunteersCompletedNCT01428284Phase 1
- A Study to Evaluate the Effects of Rifampin on Single-Dose Pharmacokinetics of Canagliflozin in Healthy VolunteersCompletedNCT01395927Phase 1
- A Study to Evaluate the Effect of JNJ-28431754 (Canagliflozin) on Post-Meal Glucose in Patients With Type 2 Diabetes MellitusCompletedNCT01381887Phase 1
- The Effect of Food on the Administration of Canagliflozin in Healthy Adult VolunteersCompletedNCT01343290Phase 1
- A Pharmacokinetic Dose Proportionality Study of Canagliflozin in Healthy VolunteersCompletedNCT01340677Phase 1
- A Pharmacodynamics, Pharmacokinetics, and Safety Study of Hydrochlorothiazide and Canagliflozin in Healthy VolunteersCompletedNCT01294631Phase 1
- A Pharmacokinetic and Pharmacodynamic Study of Once-Daily and Twice-Daily Dosing With Canagliflozin in Healthy Adult VolunteersCompletedNCT01286103Phase 1
- A Single and Multiple Dose Study of Canagliflozin in Healthy VolunteersCompletedNCT01281579Phase 1
- A Pharmacokinetic and Pharmacodynamic Study of Metformin and Canagliflozin in Healthy Adult VolunteersCompletedNCT01273571Phase 1
- A Study of Two Methods for Determining the Renal Threshold for Glucose in Patients With Type 2 Diabetes MellitusCompletedNCT01273558Phase 1
- A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult VolunteersCompletedNCT01195324Phase 1
- A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) FunctionCompletedNCT01186588Phase 1
- A First-in-Human Study of JNJ-28431754 in Healthy Male VolunteersCompletedNCT01177150Phase 1
- A Pharmacokinetic and Bioavailability Study of 28431754 (Canagliflozin) in Healthy Male VolunteersCompletedNCT01157000Phase 1
- A Pharmacokinetic and Pharmacodynamic Study to Determine Blood Levels of JNJ-28431754 (Canagliflozin) in Patients With Type 2 Diabetes MellitusCompletedNCT01128985Phase 1
- A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes MellitusCompletedNCT00963768Phase 1